<DOC>
	<DOCNO>NCT00627809</DOCNO>
	<brief_summary>The investigator hypothesize complementary intracoronary streptokinase administration primary percutaneous intervention patient acute myocardial infarction may provide limitation infarct size improvement leave ventricular volume function acute late phase ( 6 month ) .</brief_summary>
	<brief_title>Effect Adjunctive Intracoronary Streptokinase Late Term Left Ventricular Infarct Size Volumes Patients With Acute Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Reperfusion Injury</mesh_term>
	<mesh_term>Streptokinase</mesh_term>
	<criteria>Continuous chest pain last &gt; 30 minute within precede 12 hour STsegment elevation least 1 mm 2 contiguous lead ECG Infarct related artery ( IRA ) occlusion ( TIMI grade 0 ) angiography Contraindications streptokinase , tirofiban , aspirin , clopidogrel , heparin Culprit lesion saphenous vein graft TIMI grade IIIII flow IRA Additional epicardial stenosis IRA distal stented segment ( significant insignificant ) Presence leave bundle branch block History prior MI</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>coronary microcirculation</keyword>
	<keyword>acut myocardial infarction</keyword>
	<keyword>infarct size</keyword>
	<keyword>streptokinase</keyword>
	<keyword>reperfusion</keyword>
</DOC>